Tourmaline Bio Inc (TRML) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TRML Annual Balance Sheets →
Looking at balance sheet data from Tourmaline Bio Inc through Jun 30 2024 provides insight into Jun 30 2025's solvency and capital structure over time.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2025)
(Mar 31 2025) (Dec 31 2024) (Sep 30 2024) (Jun 30 2024)
Assets
Cash & cash equivalent31.42
Available-for-sale Securities, Debt Securities, Current MA207.81
Cash & Short-term Investments238.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current9.87
Total Current Assets249.10
Equipment/Property/Plant Net0.05
Long-term investments17.18
Other Assets, Noncurrent3.00
Operating Lease Right Of Use Asset0.13
Total Assets269.30
Liabilities
Accounts Payable, Current AC3.17
Accrued Liabilities, Current AC6.78
Other Liabilities, Current0.00
Total Current Liabilities10.10
Total Long-term Debt0.00
Other liabilities, Noncurrent0.01
Operating Lease Liability Current0.15
Operating Lease Liability Noncurrent-
Total Liabilities10.10
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock440.39
Retained Earnings / Accumulated Deficit-181.32
Other Equity0.12
Common Stockholder's Equity259.19
Total Stockholder's Equity259.19
Liabilities & Stockholder's Equity269.30
4 historic quarters locked

Sign in to unlock the full Tourmaline Bio Inc balance sheet history.

About Tourmaline Bio Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001827506-25-000098

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.